Literature DB >> 4013682

Localization of experimental glioma grafts by means of iodinated monoclonal antibodies and radionuclide imaging.

D Stavrou, W Mellert, T Bilzer, R Senekowitsch, E Keiditsch, P Mehraein.   

Abstract

Purified McAbs (14AC1) of IgG2a isotype raised against an experimental rat glioma (79FR-G-41) were labeled with Na131I and used for in vivo imaging of glioma grafts by external body scintigraphy. Normal mouse 131I-IgG was applied as control for non-specific uptake of proteins in the tumor. Nude mice bearing glioma grafts were injected i.v. with 15 micrograms of the 131I-McAb or 131I-IgG with an activity of approximately 150 microCi. Scans obtained 30 min, 24, 48, 72, and 96 h after injecting the intact 131I-14AC1 antibody demonstrated enrichment of radioactivity in the tumors. The tumors were clearly visible 48 h after injection of 131I-labeled antibody. The time course experiments showed that the uptake of 131I-14AC1 antibody in the glioma grafts was the result of specific antigen binding. Intact antibody provided adequate tumor visualization in the scintigrams without background subtraction. Therefore, this technique appears promising for in vivo tumor detection and may offer the possibility of improvement in the evaluation of diagnostic and therapeutic approaches to human gliomas.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4013682     DOI: 10.1007/bf00690968

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  11 in total

1.  THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.

Authors:  F C GREENWOOD; W M HUNTER; J S GLOVER
Journal:  Biochem J       Date:  1963-10       Impact factor: 3.857

2.  The in vivo localization of anti-Wagner-osteogenic-sarcoma antibodies.

Authors:  D PRESSMAN; L KORNGOLD
Journal:  Cancer       Date:  1953-05       Impact factor: 6.860

3.  Radioimmunodetection of Cancer.

Authors:  A A Epenetos; W F Bodmer; K E Britton
Journal:  Eur J Cancer Clin Oncol       Date:  1982-11

4.  Monoclonal antibody localization in subcutaneous and intracranial human glioma xenografts: paired-label and imaging analysis.

Authors:  M A Bourdon; R E Coleman; R G Blasberg; D R Groothuis; D D Bigner
Journal:  Anticancer Res       Date:  1984 May-Jun       Impact factor: 2.480

5.  Tumor location detected with radioactively labeled monoclonal antibody and external scintigraphy.

Authors:  B Ballou; G Levine; T R Hakala; D Solter
Journal:  Science       Date:  1979-11-16       Impact factor: 47.728

6.  Monoclonal antibodies reactive with glioma cell lines derived from experimental brain tumors.

Authors:  D Stavrou; C Süss; T Bilzer; U Kummer; N De Tribolet
Journal:  Eur J Cancer Clin Oncol       Date:  1983-10

7.  Radioimmunodetection of gliomas by administration of radiolabelled monoclonal antibodies. Experimental data.

Authors:  D Stavrou; W Mellert; T Bilzer; R Senekowitsch; E Keiditsch; P Mehraein
Journal:  Anticancer Res       Date:  1985 Mar-Apr       Impact factor: 2.480

8.  Radioimmunodetection of human tumor xenografts by monoclonal antibodies.

Authors:  D Herlyn; J Powe; A Alavi; J A Mattis; M Herlyn; C Ernst; R Vaum; H Koprowski
Journal:  Cancer Res       Date:  1983-06       Impact factor: 12.701

9.  Localisation of malignant glioma by a radiolabelled human monoclonal antibody.

Authors:  J Phillips; T Alderson; K Sikora; J Watson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-05       Impact factor: 10.154

10.  Tumor localization of radiolabeled antibodies against carcinoembryonic antigen in patients with carcinoma: a critical evaluation.

Authors:  J P Mach; S Carrel; M Forni; J Ritschard; A Donath; P Alberto
Journal:  N Engl J Med       Date:  1980-07-03       Impact factor: 91.245

View more
  1 in total

1.  Growth inhibition of experimental glioma grafts by monoclonal antibody treatment.

Authors:  D Stavrou; W Mellert; U Mellert; E Keiditsch; K Bise; P Mehraein
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.